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Abstract
Recent discoveries highlight the importance of stochastic epigenetic changes, as indexed
by epigenetic outlier DNA methylation signatures, as a valuable tool to understand aberrant
cell function and subsequent human pathology. There is evidence of such changes in differ-
ent complex disorders as diverse as cancer, obesity and, to a lesser extent, depression.
The current study was aimed at identifying outlying DNA methylation signatures of depres-
sive psychopathology. Here, genome-wide DNA methylation levels were measured (by
means of Illumina Infinium HumanMethylation450 Beadchip) in peripheral blood of thirty-
four monozygotic twins informative for depressive psychopathology (lifetime DSM-IV diag-
noses). This dataset was explored to identify outlying epigenetic signatures of depression,
operationalized as extreme hyper- or hypo-methylation in affected co-twins from discordant
pairs that is not observed across the rest of the study sample. After adjusting for blood cell
count, there were thirteen CpG sites across which depressed co-twins from the discordant
pairs exhibited outlying DNA methylation signatures. None of them exhibited a methylation
outlier profile in the concordant and healthy pairs, and some of these loci spanned genes
previously associated with neuropsychiatric phenotypes, such as GHSR and KCNQ1. This
exploratory study provides preliminary proof-of-concept validation that epigenetic outlier
profiles derived from genome-wide DNA methylation data may be related to depression risk.
Introduction
Recent discoveries, mainly in the field of cancer research, highlight the importance of differen-
tially variable methylation signatures as a valuable tool to understand cellular biology [1,2].
Accordingly, new studies are providing biologically-plausible frameworks to understand the
origins and implications of such stochasticity-related epigenetic modifications [3–5]. Beyond
environmental altering DNA methylation, recent data support the idea of epigenetic
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stochasticity as an important modifier of DNA methylation. Epigenetic stochasticity refers to
themutation of epigenetic marks in the absence of detectable environmental influences, such
as in events where DNA methylation marks are not replicated [6,7].
Epigenetic stochasticity, as indexed by DNA methylation variability, has become a very
popular candidate mechanism in studies of cancer cell biology [8–10]. Notably, the importance
of DNA methylation variability to unravel disease aetiology and dynamics does not seem lim-
ited to the field of cancer. For instance, there is some evidence of increased DNA methylation
variability in obesity [11] and in depression [12–16]. This clinical background confers particu-
lar importance to the study of stochastic epigenetic changes in diseased populations, as they
may be linked to aberrant cell function and subsequent human pathology.
Due to the novelty of this subject, only a few tools to statistically assess differences in DNA
methylation variability between health and disease have been developed to date [17–19]. Most
of these tools have mainly been used in cancer, and incorporate statistical methods in which
outlier observations in the healthy and affected DNA samples are purposefully removed before
the analyses [17,18]. However, further research has indicated that epigenetic outliers may be
frequent across a broad set of pathological states, and could probably function as disease mark-
ers [19].
The translatability of the above mentioned techniques to phenotypes apart from cancer
comes from previous evidence of a sound epigenetic influence in a wide range of complex phe-
notypes [7,20]. In this sense, perhaps one of the clearest applications of these approaches out-
side the field of cancer is the work of Xu et al. [11], who showed an increase in the number of
DNA methylation sites with outlier methylation within a group of obese individuals. Neverthe-
less, applying these methods to pathological states such as mental disorders is not straightfor-
ward, since their epigenetic dynamics and the statistical properties of the data extracted from
them may have some particularities [16,21]. As described by Mill and Petronis [21], several
environmental factors and gene-environment interactions associated with depression are hard
to explain: e.g., the prevalence of depression in women almost doubles the prevalence in men
after puberty, and depression has a sharp rise in prevalence in women after puberty. Addition-
ally, epigenetic changes observed in psychiatric disorders are quite subtle, i.e. DNA methyla-
tion absolute changes reported in the literature are limited, typically under 5%; nevertheless,
such small changes may be sufficient to impact mental health [22,23].
As reported by Oh et al. [16] in a sample of monozygotic twin pairs discordant for major
depressive disorder, depressed individuals exhibited a statistically significant higher number of
epigenetic outliers, in both gene coding and intergenic regions, when compared to healthy
subjects. Although these previous findings indicate that there are epigenetic outliers spanning
the whole (epi)genome of depressed individuals [16], further research may allow substantiate
these findings with standard methods and to determine the precise genomic loci where DNA
methylation outliers could be frequent in psychopathology.
The present work aims to confirm the biological feasibility of epigenetic outlier signatures
in depressive disorders. To test for variable (outlying) methylation levels at the CpG level asso-
ciated with depression, the authors analyzed a DNA methylation dataset from the Illumina
Infinium HumanMethylation450 Beadchip, which covers >450,000 CpG sites across the
human genome. Data for this pilot evaluation came mainly from a set of six monozygotic
(MZ) adult twin pairs (12 individuals) discordant in their liability for depressive psychopathol-
ogy, and groups of concordant and healthy individuals (4 and 7 MZ pairs, respectively) were
used to further validate the findings. Using MZ twin samples to analyze methylation variability
in disease status has the advantage of suppressing potential sources of methylation variance
due to DNA sequence variation. Namely, the potential bias of single nucleotide polymorphism
(SNP)-containing probes [24,25] is controlled.
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Results
After multiple testing adjustments, affected co-twins from discordant MZ pairs showed
increased DNA methylation variance at sixteen CpG probes spanning the whole genome
(Fig 1).
As described inMaterials and methods, an additional analysis step was conducted to discard
CpG probes showing statistical significance due to potential technical artifacts, or perhaps
lacking biological relevance. Specifically, former research indicates that the Illumina technol-
ogy employed here is able to detect DNA methylation differences of 10% or more with a low
probability of error, and there is also evidence showing that methylation differences above
10% are likely to have important functional consequences [13,26–28]. Accordingly, the ranges
of DNA methylation values were estimated in both the healthy and affected co-twin subsets,
for all 16 CpG probes with increased DNA methylation variance in affected individuals. Since
3 of these probes had only slight increases in DNA methylation ranges (< 10%) in the affected
co-twins, they were discarded from the next discussion and analysis steps.
Fig 2 depicts the DNA methylation values observed in the 6 discordant twin pairs at the
remaining 13 probes. Two main observations can be derived from that data. First, the DNA
methylation variance increases in depression are driven by epigenetic outliers, rather than by a
homogeneous distribution of the methylation values in the affected co-twins (i.e., typically
only one of the six affected co-twins constitutes an outlier observation, increasing the overall
Fig 1. Sixteen DNA methylation probes across the genome exhibit larger methylation variance in the depression-
affected co-twins than in their healthy counterparts. The statistical significance of these p-values is already adjusted
for multiple comparisons using the FDR protocol proposed by Storey and Tibshirani (2003).
https://doi.org/10.1371/journal.pone.0207754.g001
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variance of the group). This fact somehow confirms the feasibility of the adopted statistical
protocol (F-tests of variance) to detect outlying observations. Secondly, across the 13 probes, it
seems that only two out of the six affected co-twins show epigenetic outlier signatures (pairs 5
and 6: blue and pink lines).
Table 1 shows descriptive information on the 13 CpG probes across the genome showing
an epigenetic outlier-like profile in depression. The names of the genes they span are also
shown, as well as a brief overview of their potential involvement in depression and related
brain and behavioral phenotypes.
As an additional validation procedure, the distributions of DNA methylation profiles for
the same 13 probes were also analyzed in the subsets of healthy and depression-concordant
MZ pairs. If the outlier methylation profiles observed in the affected co-twins from discordant
pairs were solely due to technical artifacts or not related to the disease etiology/manifestation,
healthy and concordant pairs may show high-variance distributions. The results of these analy-
ses are depicted in Fig 3.
Discussion
The current study evaluated the feasibility of an epigenetic outlier structure in DNA methyla-
tion profiles of depressed individuals. The statistical approach adopted here was customized to
account for the fact that, as previously indicated in the literature, both healthy and depressed
co-twins may exhibit epigenetic outlier profiles at specific CpG sites across the genome [16].
Most of the CpG sites with outlier distributions in the affected co-twins from depression-dis-
cordant pairs were located at genes previously associated with neuropsychiatric and related
phenotypes, likely indicating that they have functional consequences on relevant neuropsychi-
atric pathways. Hence, the results offer a preliminary proof-of-concept validation of a methyla-
tion outlier structure in depression, and propose data analysis guidelines to evaluate this
epigenetic phenomenon in samples of depressed individuals, where the statistical distribution
of DNA methylation levels could differ from other phenotypes.
Fig 2. CpG probes with large and statistically significant DNA methylation variances in the diagnostic-discordant MZ twins. The
thirteen probes displayed here are those with genome-wide statistically significant methylation variance increases in affected co-twins
from the discordant pairs. PairID: randomly assigned pair number.
https://doi.org/10.1371/journal.pone.0207754.g002
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Table 1. DNA methylation probes showing outlier distributions in the affected co-twins from the six adult MZ pairs discordant for depression, and potential neuro-
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DNA methylation levels at the thirteen identified CpG probes were retrieved for the groups
of diagnostic-concordant and healthy pairs, to explore whether they also exhibited a similar
outlier profile regardless of psychopathological status. As shown in Fig 3, most probes exhibit
similar ranges of values (and, accordingly, similar variances) across pairs of co-twins, regard-
less of whether they are concordant or healthy. A number of specificities on the statistical dis-
tributions should be noted, as they may provide complementary information. For instance,
both co-twins of one of the healthy pairs (pair ID: 13) exhibit an outlier-like profile at CpG
sites cg00002719, cg00100121 and cg08104202. However, both co-twins in this pair have
almost identical methylation levels at these sites suggesting that their particular genomic DNA
sequences may contain low-frequency SNVs associated with hyper-methylation such as SNP-
containing probes [24,25]. Alternatively, the shared methylation profile could have arised in
response to an environmental exposure common to both co-twins of the pair [29]. Thus, the
relatively high methylation levels at these probes are not actually indicating stochastic epige-
netic effects in healthy pairs. Rather, the plots would somehow indicate that methylation levels
at these three CpG sites can be genetically-regulated, but this observation does not invalidate
the epigenetic-outlier pattern observed in the discordant subset. Namely, in the present sam-
ple, affected co-twins from discordant pairs showed an outlier profile regardless of their DNA
sequence match with their healthy counterparts.
Besides, probes cg08530065, cg11796442, cg12469257 and cg22070855 also show relatively
large variances (Fig 3). But as displayed, these CpG sites had similar methylation levels in both
co-twins from each pair: the intrapair differences in DNA methylation are typically less than
5%, which may be due to technical measurement artifacts and/or have small functional effects.
In this regard, 15 mQTLs have been described to influence cg08530065 methylation, as
retrieved from the mQTL database [30]. In contrast, larger methylation differences were
observed when comparing the affected co-twin with outlier profile with the healthy co-twin
(Table 1 and Fig 2). Hence, analysis of DNA methylation profiles at the thirteen candidate
probes (retrieved from the diagnostic-discordant pairs), suggest that outlying methylation pro-
files are related to diagnostic status. This analysis may also suggest that the outlier profiles are
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Note that no SNPs have been described in any of the CpG sites exhibiting outlier distributions. �Brain-blood correlations were retrieved from the Blood Brain DNA
Methylation Comparison Tool, a publicly available database [56].
Abbreviations: TargetID, Illumina identifier; 1stExon, first exon; 5’UTR, 5’ untranslated region; Body, within gene body; TSS200, within 200 bp of a TSS.
https://doi.org/10.1371/journal.pone.0207754.t001
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Regarding similar research studies, previous population-based clinical reports had used
analogous statistical approaches with data from genetically independent individuals with non-
psychiatric phenotypes (i.e., singletons; for instance Xu et al. [11]). By definition, DNA
sequence variants such as SNPs are equally represented across healthy and depressed co-twin
samples. Accordingly, the current study takes advantage of the DNA sequence parity between
MZ co-twins discordant for depression to show the presence of epigenetic outliers in affected
co-twins, regardless of some SNPs that may be present across the general population.
Additionally, a recent report by Oh et al. [16] has found that epigenetic outliers can be
found in both depressed and control populations–though they are more frequent in samples
from depressed individuals–. The current report somehow expands on this topic by suggesting
that DNA methylation variability due to epigenetic outliers may be related to the neurobiologi-
cal mechanisms underlying depressive physiopathology. Although there is no clear mechanism
about how these epigenetic changes can affect neurobiology downstream, it is important notic-
ing that the identified probes were found within genes and may have relatively direct func-
tional effects on those. Namely, as shown in Table 1, most of the CpG probes found with an
epigenetic outlier profile in the affected co-twins from discordant pairs are located within the
genomic coordinates of genes previously studied in the literature of psychiatric disorders. In
agreement with the findings by Oh et al. [16], our results indicate that DNA methylation vari-
ance analyses in depressed individuals should be conducted using one-tailed tests, since some
CpG probes with increased variance in normal control samples may be present and mislead
Fig 3. Assessment of DNA methylation levels in diagnostic-concordant and healthy pairs at the 13 CpG probes with epigenetic
outlier profiles in affected co-twins from discordant pairs. The thirteen probes displayed here are those with genome-wide
statistically significant methylation variance increases in affected co-twins from the discordant pairs (see Fig 2). PairID: randomly
assigned pair number.
https://doi.org/10.1371/journal.pone.0207754.g003
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the biological meaning of the results. Perhaps the most suggestive genes from this set are the
ghrelin receptor (GHSR), the potassium channel, voltage gated KQT-like subfamily Q, mem-
ber 1 (KCNQ1) and the potassium voltage-gated channel subfamily D member 2 (KCND2).
Ghrelin plays an important role in a broad spectrum of psychopathological outcomes, includ-
ing stress, mood-and anxiety disorders [31], probably by modifying brain reward circuitry
[32]. Similarly, there is evidence suggesting that KCNQ1may be related to psychopathological
phenotypes [33], and peripheral tissue DNA methylation levels of KCNQ1 have been shown to
correlate with both adult personality traits [34] and psychiatric symptoms during the first
years of life [35]. As opposed to KCNQ1, which is predominantly expressed in the adrenal
glands and the thyroid, KCND2 is most expressed in brain tissue; KCND2 genetic variants
have been associated with both epilepsy and autism [36]. Interestingly, CpG probes identified
in this set of genes exhibit methylation correlation across blood and brain tissue (see Table 1).
There are several limitations of this study to be noted. First, due to the statistical approach
focused in discordant twin pairs, the sample size to estimate DNA methylation outliers was
limited to only 6 twin pairs. Each of the epigenetic changes reported here was observed on one
discordant pair at a time, suggesting that stochastic factors could be underlying the results,
rather than non-shared environment across discordant pairs. However, there is no conclusive
evidence against the hypothesis of DNA methylation outliers caused by environmental factors
in the current analysis. Additionally, due to the cross-sectional nature of the study and the
inclusion of subjects with both prior and current history of anxious-depressive disorders, cau-
sality of observed DNA methylation outliers cannot be established. Finally, none of the
reported hits have been previously described in association with depression.
In summary, the present results suggest that, alongside other methylation variability mecha-
nisms recently shown in the literature of depression [12–15], epigenetic outliers may index
biological disruptions underlying the etiopathology and clinical manifestation of depression.
Materials and methods
Subjects
The participants of this study were part of a larger twin sample (UB-Twin Registry) consisting
of 242 Caucasian Spanish adult twins from the general population who gave permission to be
contacted for research purposes. The exclusion criteria included age under 18 and over 65
years, a medical history of neurological disturbance, presence of sensory or motor alterations
and current substance misuse or dependence. Written informed consent was obtained from all
participants after a detailed description of the study aims and design, as approved by the Bio-
ethics Committee of the University of Barcelona. All procedures contributing to this work
were performed in accordance with the Helsinki Declaration of 1975, as revised in 2008.
Trained psychologists applied face-to-face interviews to apply a battery of psychological
and neurocognitive tests and to obtain medical records information. Additionally, peripheral
blood or saliva samples were obtained from all 242 participants. The zygosity of the pairs was
determined by genotyping 16 highly polymorphic microsatellite loci from DNA samples
(SSRs; PowerPlex 16 System Promega Corporation). Identity on all the markers can be used to
assign monozygosity with greater than 99% accuracy [37].
A group of 34 middle-aged participants (17 MZ twin pairs; age range 22–56, median age 38;
47% female) who were representative and informative for psychopathology, neurocognition
and related factors was extracted from the above-described sample, to be investigated for brain
function and genome-wide epigenetic signatures. Peripheral blood was available from all
members of this group. Regarding depressive status of the participants, there were 6 discor-
dant, 4 concordant and 7 healthy MZ pairs (12, 8 and 14 individuals). Further information
Epigenetic outlier profiles in depression
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about these participants can be found elsewhere [13,38]; the specific categorical DSM-IV based
diagnoses of all subjects are detailed in S1 and S2 Tables. The main analyses described in this
manuscript were conducted with the six discordant pairs, and complementary confirmatory
analyses were carried out with the concordant and healthy pairs.
Clinical evaluation
A trained clinical psychologist applied the Structural Clinical Interview for DSM-IV Axis I Dis-
orders (SCID-I) [39] in a face-to-face interview to screen for the presence of any lifetime depres-
sion or related anxiety spectrum disorder. Only two out of the twelve participants in this study
had predominantly liability for anxious psychopathology. This apparently broad category of dis-
orders was adopted in view of the evidence on comorbidity, shared etiopathology and diagnos-
tic criteria overlap between depressive and anxious disorders [40–44], as well as taking into
account evidences of some shared DNA methylation mechanisms in these diagnoses [40,45].
Complementarily, on the day of blood extraction, the current psychopathological status of
all participants was evaluated with the Brief Symptom Inventory (BSI) [46,47]. This self-
administered 46-item questionnaire is aimed at identifying the experience of psychopathologi-
cal symptoms during the last 30 days. Its six subscales (depression, phobic anxiety, paranoid
ideation, obsession-compulsion, somatization and hostility) were conceived for use in both
clinical and non-clinical settings. All items are rated on a 5-point likert scale of distress,
according to self-perception of symptoms. There were no between-group differences in intel-
lectual quotient distributions, and the whole sample showed overall intelligence level profiles
similar to those reported for demographically analogous samples [48]. Summarized informa-
tion is shown in Table 2.
Methylation data
The Illumina Infinium HumanMethylation450 (450K) BeadChip [49,50] was employed with
peripheral blood DNA samples for all participants. Specifically, by genotyping sodium bisul-
fite-treated DNA, DNA methylation is assayed by this platform at> 450 000 CpG sites across
the genome at single-base resolution; next, bisulfite-converted DNA undergoes whole-genome
amplification, before being fragmented and hybridized to microarray probes. The DNA meth-
ylation fraction of each CpG site is estimated as β =M / (M + U + α);M and U stand for meth-
ylated and unmethylated fluorescence intensities, and α is an arbitrary offset applied to
stabilize β values with low intensities.
Table 2. Psychopathological, neurocognitive and demographic variables for DSM-IV diagnostic concordant, discordant and healthy MZ twin pairs.
CONCORDANT
(8 subjects, 8 female)
DISCORDANT
(12 subjects, 4 female)
HEALTHY
(14 subjects, 4 female)
Group comparison
Mean (SD) Range Mean (SD) Range Mean (SD) Range X-squareda; p
Age 42.5 (13) 22–54 37 (10.9) 20–50 30.3 (7.3) 19–39 5.9; 0.052
IQ 105.1 (12.5) 87–127 108.1 (11.8) 87–131 110.5 (5.5) 103–118 1.9; 0.393
Current psycho-pathology (total BSI) 27.9 (16.5) 6–57 20.9 (13.3) 4–45 10.6 (9.3) 1–33 8.7; 0.013�
Current depressive symptoms (BSI subscale) 6.9 (6.5) 1–20 3.5 (2.7) 0–9 1.7 (1.8) 0–6 6.4; 0.04�
Subjects from discordant twin pairs exhibit intermediate BSI scores (as compared with subjects from healthy or concordant groups) since they constitute a 50% of
affected and a 50% of non-affected subjects (their individual scores being averaged).
Notes: SD, standard deviation; IQ, intellectual quotient; BSI, Brief Symptom Inventory
a, Kruskal-Wallis X-squared, as these variables were continuous
�, statistically significant p-value.
https://doi.org/10.1371/journal.pone.0207754.t002
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Infinium methylation data was processed with Methylation Module of GenomeStudio soft-
ware using HumanMethylation450 manifest v1.1 following the instructions published by Bibi-
kova et al. [49] CpG sites with poor detection quality (p> 10−4) were removed from further
analysis.
The obtained DNA methylation data was further processed to adjust for cell mixture distri-
bution. Briefly, the proportions of different mononuclear cell populations and granulocytes
were calculated following a previously published protocol [51,52]. By using 493 probes that
matched the informative CpG sites reported by Houseman et al. [51], the proportions of six
different cell types (B, CD4+ T and CD8+ T lymphocytes, plus monocytes, natural killer cells
and granulocyte contamination) were estimated across the>450,000 measurements from the
Illumina array. Afterwards, a penalized regression procedure allowed retrieving a β value rep-
resenting the average cell. A software function to perform this cell mixture adjustment proto-
col is publicly available at https://gist.github.com/brentp/5058805#file-houseman-r. As
expected, results using the adjusted β were more conservative than those using the unadjusted
methylation values (i.e., there were less statistically significant CpG probes when using the
adjusted β value).
Since the present MZ twin sample contains both male and female participants, probes in
the X and Y chromosomes were removed from the analyses to avoid confounding. Likewise, in
view of the relatively small sample size, all CpG probes for which at least one of the 12 diagnos-
tic-discordant individuals had a missing value were removed, giving a final number of 473,864
probes.
The dataset supporting the results of this article have been deposited in NCBI’s Gene
Expression Omnibus and is accessible through GEO SuperSeries accession number
GSE120307.
Statistical analyses
In order to find CpG probes in which depressed co-twins from discordant MZ twin pairs
exhibited outlier DNA methylation signatures, independent F-tests were conducted at each of
the 473,864 probes across chromosomes 1 to 22 using var.test() in R. The F-test was imple-
mented using standard procedures as follows. First, let �X ¼ 1n
Pn















i¼1 ðYi   �YÞ
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be the sample




, and it has an F-distribution under the null
hypothesis with n-1 and m-1 degrees of freedom. These tests allowed assessing the null
hypothesis that the variances of both healthy and affected co-twin groups were equal. This test
was chosen to detect epigenetic outlier measurements since it is highly sensitive to departures
from normality in a statistical distribution (i.e., outliers) [53]. Considering the evidence of a
large number of CpG probes with increased epigenetic outlier features in normal populations
when compared to depressed individuals [16], it is necessary controlling for the fact that, in
some cases, the control group may display greater variance than the affected group. Hence,
one-tailed versions of the F-test were implemented.
Multiple testing adjustments were conducted using q-values, a measure based upon the
false discovery rate (FDR) that has been shown useful in genome-wide statistical analyses and
other large-scale multiple comparison settings [54,55]. Values of q–the multiple-comparison-
adjusted version of p–below a 0.05 threshold were considered statistically significant.
An additional filter was applied to the CpG probes obtained from the former procedure. As
previous reports indicate that methylation differences above 10% in Illumina assays may have
important biological implications and show a low probability of being technical artifacts
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[13,26–28], a DNA methylation measurement was considered an “outlier” if, apart from being
statistically significant at q� 0.05, the between-group (healthy vs. depressed) difference in
methylation ranges was above 10%.
Information regarding brain and blood correlation of DNA methylation values at the CpG
probes meeting the aforementioned outlier criteria was retrieved from the Blood Brain DNA
Methylation Comparison Tool, a publicly available database [56].
Finally, the names of the genes containing epigenetic outlier probes only within depressed
individuals were retrieved to further evaluate the biological feasibility of the results. All analy-
ses, as well as all data visualization procedures, were conducted using some packages for the R
software [57–60].
Supporting information
S1 Table. DSM-IV based categorical diagnosis of affected subjects within discordant twin
pairs. Pairs 5 and 6, exhibiting outlier methylation profiles have been highlighted in light grey.
When a subject met criteria for several categorical entities, those were separated by “/”. Abbre-
viations: NOS, not otherwise specified.
(DOCX)
S2 Table. DSM-IV based categorical diagnosis of subjects within concordant twin pairs.
When a subject met criteria for several categorical entities, those were separated by “/”. Abbre-
viations: NOS, not otherwise specified.
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4. Lévesque ML, Casey KF, Szyf M, Ismaylova E, Ly V, Verner MP, et al. Genome-wide DNA methylation
variability in adolescent monozygotic twins followed since birth. Epigenetics. 2014; https://doi.org/10.
4161/15592294.2014.970060 PMID: 25437055
5. Timp W, Feinberg AP. Cancer as a dysregulated epigenome allowing cellular growth advantage at the
expense of the host. Nature Reviews Cancer. 2013. https://doi.org/10.1038/nrc3486 PMID: 23760024
6. Kebir O, Chaumette B, Krebs MO. Epigenetic variability in conversion to psychosis: Novel findings from
an innovative longitudinal methylomic analysis. Transl Psychiatry. Springer US; 2018; 8. https://doi.org/
10.1038/s41398-018-0138-2 PMID: 29695761
7. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature.
2010; 465: 721–7. https://doi.org/10.1038/nature09230 PMID: 20535201
8. Flanagan JM, Wilhelm-Benartzi CS, Metcalf M, Kaye SB, Brown R. Association of somatic DNA methyl-
ation variability with progression-free survival and toxicity in ovarian cancer patients. Ann Oncol. 2013;
https://doi.org/10.1093/annonc/mdt370 PMID: 24114859
9. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, McDonald OG, et al. Increased methyla-
tion variation in epigenetic domains across cancer types. Nat Genet. 2011; https://doi.org/10.1038/ng.
865 PMID: 21706001
10. Titus AJ, Way GP, Johnson KC, Christensen BC. Deconvolution of DNA methylation identifies differen-
tially methylated gene regions on 1p36 across breast cancer subtypes. Sci Rep. Springer US; 2017; 7:
1–9. https://doi.org/10.1038/s41598-017-10199-z PMID: 28912426
11. Xu X, Su S, Barnes VA, De Miguel C, Pollock J, Ownby D, et al. A genome-wide methylation study on
obesity: Differential variability and differential methylation. Epigenetics. 2013; https://doi.org/10.4161/
epi.24506 PMID: 23644594
12. Byrne EM, Carrillo-Roa T, Henders AK, Bowdler L, McRae AF, Heath AC, et al. Monozygotic twins
affected with major depressive disorder have greater variance in methylation than their unaffected co-
twin. Transl Psychiatry. 2013; https://doi.org/10.1038/tp.2013.45 PMID: 23756378
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